Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen: Safety and diagnostic efficacy

Acta Radiologica

Volumn 40, Issue 4, 1999, Pages 429-435

  Kivelitz, Dietmar ^a   Gehl, H B ^b   Heuck, A ^b   Krahe, T ^b   Taupitz, M ^a   Lodemann, K P ^b   Hamm, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Humboldt Universität zu Berlin ^*

Author keywords

Abdomen, MR imaging; Contrast media, Enhancement

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC AMMONIUM CITRATE; FERRIC ION; QUATERNARY AMMONIUM DERIVATIVE;

ABDOMEN; ADULT; AGED; ARTICLE; ARTIFACT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SAFETY;

ABDOMEN; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CONTRAST MEDIA; DIGESTIVE SYSTEM; DOUBLE-BLIND METHOD; FEMALE; FERRIC COMPOUNDS; GASTROINTESTINAL DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; QUATERNARY AMMONIUM COMPOUNDS; REPRODUCIBILITY OF RESULTS; SAFETY;

EID: 0033162623     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859909177759     Document Type: Article

References (20)

1. BACH-GANSMO T., ERICSSON A., LEANDER P., FAHLVIK A. K. & HEMMINGSSON A.: Motion associated susceptibility artifacts. Acta Radiol. 33 (1992), 606.
2. BRASCH R. C.: New directions in the development of MR contrast media. Radiology 183 (1992), 1.
3. GRAS (Generally recognized as safe) food ingredients -iron and iron salts. National Technical Information Service, PB-221-236, March 1973, DHEW Contract No. FDA 72-104.
4. HAHN P. F., STARK D. D., SAINI S., LEWIS J. M., WITTENBERG J. & FERRUCCI J. T.: Ferrite particles for bowel contrast in MR imaging. Design issues and feasibility studies. Radiology 164 (1987), 37.
5. HIROHASHI S., UCHIDA H., TANAKA M. et al.: Phase III study of an oral abdominal contrast agent containing ferric ammonium citrate for magnetic resonance imaging (OMR-12200). Diagn. Treat. 80 (1992), 168.
6. HIROHASHI S., UCHIDA H., YOSHIKAWA K. et al.: Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn. Reson. Imaging 12 (1994), 837.
7. KAMINSKY S., LANIADO M., GOGOLL M. et al.: Gadopentetate dimeglumine as a bowel contrast agent. Safety and efficacy. Radiology 178 (1991), 503.
8. KORNMESSER W., LANIADO M., HAMM B. et al.: Orale Kontrastmittel für die magnetische Resonanztomographie des Abdomens. Teil 2: Phase I der klinischen Prüfung von Gadolinium DTPA. RÖFO 147 (1987), 550.
9. KRAHE T., DÖLKEN W., LACKNER K., HOUSELOG M., HABSCHEID W. & CLAUSS W.: Gadolinium-DTPA als orales Kontrastmittel für die MR-Tomographie des Abdomens. RÖFO 153 (1990), 167.
10. LANIADO M., KORNMESSER W., HAMM B., CLAUSS W., WEINMANN H. J. & FELIX R.: MR imaging of the gastrointestinal tract. Value of Gd-DTPA. AJR 150 (1988), 817.
11. LI K. C., ANG P. G., TART R. P., STORM B. L., ROLFES R. & HO TAI P. C.: Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents. Magn. Reson. Imaging 8 (1990), 589.
12. LÖNNEMARK M., HEMMINGSSON A., BACH-GANSMO T. et al.: Superparamagnetic particles as oral contrast medium in MR imaging of malignant lymphoma. Acta Radiol. 32 (1991), 232.
13. MATTREY R. F., TRAMBERT M. A., BROWN J. J. et al.: Perflubron as an oral contrast agent for MR imaging. Results of a phase III clinical trial. Radiology 191 (1994), 841.
14. PATTEN R. M., LO S. K., PHILLIPS J. J. et al.: Positive bowel contrast agent for MR imaging of the abdomen. Phase II and III clinical trials. Radiology 189 (1993), 277.
15. PATTEN R. M., Moss A. A., FENTON T. A. & ELLIOTT S.: OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging. Safety and imaging characteristics. J. Magn. Reson. Imaging 2 (1992), 25.
16. RINCK P. A., SMEVIK O., NILSON G. et al.: Oral magnetic particles in MR imaging of the abdomen and pelvis. Radiology 178 (1991), 775.
17. Ros P. R., STEINMAN R. M., TORRES G. M. et al.: The value of barium as a contrast agent in MR imaging. A comparison study in normal volunteers. AJR 157 (1991), 761.
18. TART R. P., LI K. C., STORM B. L., ROLFES R. J. & ANG P. G.: Enteric MRI contrast agents. Comparative study of five potential agents in humans. Magn. Reson. Imaging 9 (1991), 559.
19. WESBEY G. E., BRASCH R. C., ENGELSTAD B. L., Moss A. A., CROOKS L. E. & BRITO A. C.: Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions. Radiology 149 (1983), 175.
20. YOSHIKAWA K., OTOMO K., KAWAMURA Y. et al.: Phase II dose-finding study of an oral abdominal contrast agent containing ferric ammonium citrate for magnetic resonance imaging (OMR 12200). Diagn. Treat. 79 (1991), 1913.